Article Details

Matrix Partners Leads $53M Series B Round In Chinese Biopharma Firm Adlai Nortye

Retrieved on: 2018-07-05 10:26:15

Tags for this article:

Click the tags to see associated articles and topics

Matrix Partners Leads $53M Series B Round In Chinese Biopharma Firm Adlai Nortye. View article details on hiswai:

Excerpt

<div>Hangzhou-based biopharmaceutical company Adlai Nortye Biopharma announced that it has raised a US$53 million series B round from <b>Matrix</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up